Navitas Pharma
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium (NCT02709031) | Navitas Pharma | 2022-06-01 |
Track Navitas Pharma automatically
Every clearance here is in the API, with alerts when new ones post.